BRAF and melanoma: Overall, ~20% of all cancers carry driver mutations in one of the genes that encode MAPK pathway proteins (Stephen et al, 2014) and in the case of melanoma, 50% of cancers carry activating point mutations in BRAF (most commonly BRAF V600E).